EMI (Encore Medical) Accounts Payable: $1.01 Mil (As of Dec. 2025)


What is Encore Medical Accounts Payable?

Encore Medical EMI Accounts Payable is $1.01 Mil as of Dec. 2025.

Encore Medical's Accounts Payable for the quarter that ended in Dec. 2025 was $1.01 Mil.

Encore Medical's quarterly Accounts Payable increased from Jun. 2025 ($0.39 Mil) to Sep. 2025 ($0.65 Mil) and increased from Sep. 2025 ($0.65 Mil) to Dec. 2025 ($1.01 Mil).

Encore Medical's annual Accounts Payable increased from Dec. 2023 ($0.09 Mil) to Dec. 2024 ($0.42 Mil) and increased from Dec. 2024 ($0.42 Mil) to Dec. 2025 ($1.01 Mil).

Encore Medical Accounts Payable Related Terms

Encore Medical Accounts Payable Historical Data

* Premium members only.

The historical data trend for Encore Medical's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Encore Medical Accounts Payable Chart

Encore Medical Annual Data
Trend Dec23 Dec24 Dec25
Accounts Payable
0.09 0.42 1.01

Encore Medical Quarterly Data
Dec23 Sep24 Dec24 Jun25 Sep25 Dec25
Accounts Payable Get a 7-Day Free Trial 0.00 0.42 0.39 0.65 1.01

Encore Medical Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $1.01 Mil mean?
Encore Medical (EMI) has a Accounts Payable of $1.01 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Encore Medical and its competitors.
Is Encore Medical's Accounts Payable too high?
Encore Medical's current Accounts Payable is $1.01 Mil.
How does Encore Medical's Accounts Payable compare to ?
Encore Medical's Accounts Payable of $1.01 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Encore Medical and its competitors. Encore Medical's current Accounts Payable is $1.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encore Medical stock overvalued right now?
Encore Medical (EMI) has a current Accounts Payable of $1.01 Mil. The current Accounts Payable is $1.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Encore Medical (EMI), the current Accounts Payable is $1.01 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Encore Medical Business Description

Comparable Companies
Address 2975 Lone Oak Drive, Suite 140, Eagan, MN, USA, 55121
Encore Medical Inc develops, manufactures, and markets septal occlusion devices for the repair of certain cardiac defects. Its products have been implanted in approximately 35,000 patients outside the United States. Its closure device is designed to correct a cardiac defect, generally diagnosed in adulthood, known as a patent foramen ovale (PFO). The company also currently market and sell septal occlusion devices for the transcatheter closure of atrial septal defects (ASD).